Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAESAR: Daclizumab and CellCept in Kidney Transplant
NCT00048152Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2000
- Primary completion
- Mar 2006
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 3 trial of daclizumab in kidney transplantation, sponsored by Roche. Started Dec 2000; status: completed.
02
Drugs
daclizumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00048152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048152.